Your search returned 1978 results.

Results
	561.	[Management of hypercholesterolemia in patients with acute coronary syndrome: current mechanisms and future perspectives]. [electronic resource] by Lettino, Maddalena Producer: 20160915 In: Giornale italiano di cardiologia (2006) vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	562.	The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia. [electronic resource] by Haas, Mary E Levenson, Amy E Sun, Xiaowei Liao, Wan-Hui Rutkowski, Joseph M de Ferranti, Sarah D Schumacher, Valerie A Scherer, Philipp E Salant, David J Biddinger, Sudha B Producer: 20161213 In: Circulation vol. 134 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	563.	A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab. [electronic resource] by McDonagh, Marian Peterson, Kim Holzhammer, Brittany Fazio, Sergio Producer: 20170428 In: Journal of managed care & specialty pharmacy vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	564.	A case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease. [electronic resource] by Di Filippo, Mathilde Vokaer, Benoit Seidah, Nabil G Producer: 20180201 In: Journal of clinical lipidology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	565.	Hepatitis C virus regulates proprotein convertase subtilisin/kexin type 9 promoter activity. [electronic resource] by Li, Zhubing Liu, Qiang Producer: 20180314 In: Biochemical and biophysical research communications vol. 496 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	566.	The genetics and screening of familial hypercholesterolaemia. [electronic resource] by Henderson, Raymond O'Kane, Maurice McGilligan, Victoria Watterson, Steven Producer: 20161014 In: Journal of biomedical science vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	567.	Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors. [electronic resource] by Blumenthal, Daniel M Goldman, Dana Jena, Anupam B Producer: 20190603 In: JAMA cardiology vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	568.	Relationship between Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and Estimated Glomerular Filtration Rate in the General Chinese Population. [electronic resource] by Zhang, Hui-Wen Zhao, Xi Xu, Rui-Xia Guo, Yuan-Lin Zhu, Cheng-Gang Wu, Na-Qiong Cui, Chuan-Jue Dong, Qian Li, Jian-Jun Producer: 20190327 In: Cardiorenal medicine vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	569.	Beyond Statins: Who and When to Prescribe? [electronic resource] by Ganda, Om Producer: 20190912 In: Current diabetes reports vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	570.	Maximizing the benefits of cholesterol-lowering drugs. [electronic resource] by Feingold, Kenneth R Producer: 20200820 In: Current opinion in lipidology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	571.	Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9. [electronic resource] by Jang, Hyun-Duk Lee, Sang Eun Yang, Jimin Lee, Hyun-Chae Shin, Dasom Lee, Hwan Lee, Jaewon Jin, Sooryeonhwa Kim, Soungchan Lee, Seung Ji You, Jihye Park, Hyun-Woo Nam, Ky-Youb Lee, Sang-Hak Park, Sahng Wook Kim, Jin-Soo Kim, Sang-Yeob Kwon, Yoo-Wook Kwak, Soo Heon Yang, Han-Mo Kim, Hyo-Soo Producer: 20210107 In: European heart journal vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	572.	The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia. [electronic resource] by Hori, Mika Takahashi, Atsushi Son, Cheol Ogura, Masatsune Harada-Shiba, Mariko Producer: 20210115 In: Lipids in health and disease vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	573.	The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. [electronic resource] by Hooper, Amanda J Marais, A David Tanyanyiwa, Donald M Burnett, John R Producer: 20071016 In: Atherosclerosis vol. 193 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	574.	Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects. [electronic resource] by Kwakernaak, Arjan J Lambert, Gilles Muller Kobold, Anneke C Dullaart, Robin P F Producer: 20130729 In: Thyroid : official journal of the American Thyroid Association vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	575.	PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment. [electronic resource] by Tveten, Kristian Str M, Thea Bismo Berge, Knut Erik Leren, Trond P Producer: 20131101 In: Journal of lipid research vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	576.	PCSK9 and lipid lowering drugs. [electronic resource] by Guo, Yuan-Lin Zhang, Wei Li, Jian-Jun Producer: 20150512 In: Clinica chimica acta; international journal of clinical chemistry vol. 437 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	577.	Cholesterol production, accumulation, reverse transport, and excretion: opportunities for statins, PPAR-α agonists, and PCSK9 inhibitors. [electronic resource] by Lüscher, Thomas F Producer: 20160913 In: European heart journal vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	578.	Knowledge of PCSK9 and continued educational gaps: evaluating the impact of continuing medical education. [electronic resource] by Larkin, Amy T Healy, Colleen S Toth, Peter P Producer: 20151201 In: Critical pathways in cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	579.	[Cloning and expression of human pcsk9 cDNA and preparation of its polyclonal antibody]. [electronic resource] by Li, Fengmei Yu, Hui Song, Jinlong Liu, Zhongmin Producer: 20131118 In: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	580.	Proprotein Convertase Subtilisin/Kexin type 9 affects insulin but not lipid metabolism in cystic fibrosis. [electronic resource] by Coriati, Adèle Arslanian, Elizabeth Bouvet, Guillaume F Prat, Annik Seidah, Nabil G Rabasa-Lhoret, Rémi Berthiaume, Yves Producer: 20180212 In: Clinical and investigative medicine. Medecine clinique et experimentale vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.